Suicidality in children and adolescents being treated with antidepressant medications

2004

Information

Guidelines/Recommendations
U.S. Food and Drug Administration (FDA)
U.S. Food and Drug Administration (FDA)

See This Resource

http://www.fda.gov/CDER/Drug/antidepressants/SSRIPHA200410.htm

FDA Public Health Advisory announcing a multi-pronged strategy to warn the public about the increased risk of suicidal thoughts and behavior (“suicidality”) in children and adolescents being treated with antidepressant medications.